Phase 3, prospective, randomized, controlled study of prophylatic and on-demand treatment of cTTP with BAX930 (rADAMTS13)
Clinical Trial Grant
Administered By
Medicine, Hematology
Awarded By
Takeda Development Center Americas, Inc
Start Date
October 2, 2019
End Date
October 14, 2024
Administered By
Medicine, Hematology
Awarded By
Takeda Development Center Americas, Inc
Start Date
October 2, 2019
End Date
October 14, 2024